Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021
Centessa Pharmaceuticals (Nasdaq: CNTA) announced that CEO Saurabh Saha will present at two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Centessa Pharmaceuticals (Nasdaq: CNTA) announced that CEO Saurabh Saha will present at two upcoming investor conferences. The first is the Jefferies London Healthcare Conference on November 18, 2021, where the presentation will be available on-demand starting at 3:00 AM ET. The second is the Evercore ISI HealthCONx Conference on December 2, 2021, featuring a fireside chat at 4:20 PM ET. Access to live webcasts and archives will be available on the Centessa investor relations website.
Details
News Market Reaction – CNTA
The recorded move for CNTA in the trading session of this news was -0.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON and LONDON, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (“Company”) (Nasdaq: CNTA) today announced that Saurabh Saha, MD, PhD, Chief Executive Officer, will present at the following investor conferences:
Event: Jefferies London Healthcare Conference
Date: Thursday, November 18, 2021
Presentation Details: Recording available on-demand on Thursday, November 18, 2021, starting at 3:00 AM ET (8:00 GMT)
Event: Evercore ISI HealthCONx Conference
Date: Thursday, December 2, 2021
Fireside Chat Details: 4:20 PM ET (21:20 GMT)
Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.
About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc aims to bring impactful new medicines to patients by combining the strengths of an asset-centric model with the benefits of scale and diversification typical of larger R&D organizations. The asset-centric model refers to a highly specialized, singular-focused company that is led by a team of well-recognized subject matter experts. Centessa’s asset-centric companies’ programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology. For more information, visit www.centessa.com.
Contacts:
Investors:
Jennifer Porcelli, Head of Investor Relations
Centessa Pharmaceuticals
jennifer.porcelli@centessa.com
Media:
1AB
Dan Budwick
dan@1abmedia.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.